Introducing Kardia 12L: The first of its kind 12-lead portable ECG | Now in India

AliveCor Logo

Our Products

Kardia 12L

New

KardiaMobile 6L
KardiaMobile
KardiaMobile Card
KardiaStation
KardiaPro
Kardia SDK

About

Leadership
Mission
Clinical Research
Newsroom
000-8000-403846
AliveCor Logo
AliveCor Logo
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
    • 000-8000-403846
    • Mission
    • Careers
    • Research
    • FAQs
    • User Manuals
    • Compatibility
    • Shipping
    • 000-8000-403846
    • Kardia 12L
    • KardiaMobile 6L
    • KardiaMobile
    • KardiaMobile Card
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • Privacy Policy
  • Security
  • Telehealth Informed Consent
  • Terms
  • Accessibility

©2024 AliveCor, Inc. All Rights Reserved. Patents www.alivecor.com/patents. AliveCor and Kardia are trademarks of AliveCor, Inc. in the United States and other countries. Apple is a trademark of Apple, Inc. registered in the U.S. and other countries. App Store is a service mark of Apple, Inc. Android is a trademark of Google Inc. Google Play is a trademark of Google Inc.

AliveCor Leadership

Frank Padron

Vice President & General Manager, BioPharma

Frank Padron is a seasoned BioPharma executive with over 25 years of experience in business development, sales, and strategic leadership. As Vice President and General Manager of BioPharma at AliveCor, he is responsible for leading the company’s success with pharmaceutical and CRO customers. Prior to joining AliveCor, Frank served as Head of North American Sales for Medichem, a global CDMO (Contract Development and Manufacturing Organization). Before that, he was the US Head of Product Licensing and Business Development at Salvat, a pharmaceutical manufacturing company. His career began at Novartis, where he held diverse positions over 17 years, including roles in Sales, Operations, Managed Markets, and Patient Advocacy, which gave him a broad perspective on the industry. His career is defined by a deep understanding of the biopharma landscape and a track record of driving strategic growth